Hers vs Ivy Rx
Ivy Rx costs $24 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →
Ivy Rx
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Ivy Rx →If you are choosing between Hers and Ivy Rx, the first difference is cost: Ivy Rx is $24 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Ivy Rx leads our six-part score, 7.3 to 7.0.
Hers vs Ivy Rx price
Ivy Rx is the cheaper way in: $175 a month against $199 a month at Hers. That is $24 less each month (12% lower), or about $288 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Ivy Rx ($175 a month vs $199 a month); tirzepatide is cheaper at Ivy Rx ($275 a month vs $299 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Hers prices compounded injections and brand-name pens, while Ivy Rx prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
Hers lists 50 states, and Ivy Rx lists 50 states.
They overlap in 50 states.
Pricing
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
Ivy Rx
Range up to $197/mo
Range up to $297/mo
What each price covers
Both prices cover the medication itself.
Ivy Rx's price also covers the clinician visit and shipping, which Hers does not claim.
Hers is silent on shipping and lab work.
Ivy Rx is silent on lab work and coaching.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Ivy Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Ivy Rx scores 7.3 and Hers 7.0 out of 10.
Hers is stronger on trust & safety (8.5 vs 7.5).
Ivy Rx is stronger on support (7.0 vs 3.0).
Value, effectiveness, user experience and accessibility are within half a point.
Hers
7.0/10
Ivy Rx
7.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Hers nor Ivy Rx has an FDA warning letter on record with us.
Features & Coverage
| Feature | Hers | Ivy Rx |
|---|---|---|
| Starting Price | $199/mo | ✓$175/mo |
| Features | 2 features | ✓3 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →About Ivy Rx
Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.
Read our full Ivy Rx review →Pros & Cons
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Ivy Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Ivy Rx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Ivy Rx wins this one, 7.3 to 7.0, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $24 less each month than Hers. Hers fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose Ivy Rx if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →Hers vs Ivy Rx: FAQ
Close alternatives to Hers and Ivy Rx
- Hers vs Hims
- Hers vs Noom
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
- Ivy Rx vs DudeMeds
- Ivy Rx vs Curve
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.